Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lifeist Wellness Inc V.LFST

Alternate Symbol(s):  LFSWF

Consumer Defensive Food Distribution Cannabis Health Care
Lifeist Wellness Inc. is a Canada-based health-tech company. The Company leverages advancements in science and technology to develop innovative products to support human wellness and transform lives. The Company's key asset is its United States biosciences subsidiary Mikra Cellular Sciences Inc. (Mikra), a biosciences and consumer wellness company focused on developing and selling products. Mikra's products consists of Focus, Protect, Serenity, and CELLF.


TSXV:LFST - Post by User

Lifeist Wellness Inc
Bullboard Posts
User Avatar Image
(78)
•••
Comment by aurorahighon Oct 01, 2018 7:25pm
75 Views
Post# 28725569

RE:RE:RE:RE:RE:RE:RE:RE:Revenue of 18,000 patients to 50,000!!! POTENTIAL!!!!

RE:RE:RE:RE:RE:RE:RE:RE:Revenue of 18,000 patients to 50,000!!! POTENTIAL!!!!You could use that same argument across many co in the sector.  Regardless of bearish momentum at the moment N has increased its value greatly by getting their license.  
Still a fledging industry and these companies don't subscribe to rational yet.  We are early on a global  shift. N is positioned well to capture an increasing % of the market.   

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities